Relapsed Small Cell Lung Cancer Clinical Trials
0 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
Relapsed Small Cell Lung CancerRecurrent Small Cell Lung Cancer
VA Office of Research and Development166 enrolled11 locationsNCT06681220
Recruiting
Phase 3
Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
Relapsed Small Cell Lung Cancer
Luye Pharma Group Ltd.180 enrolled1 locationNCT06496048
Recruiting
Phase 3
Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer
Relapsed Small Cell Lung Cancer
Luye Pharma Group Ltd.686 enrolled1 locationNCT06128837